Hunter Williams
23 September 2025
Get My Book On Amazon: https://a.co/d/avbaV48Download The Peptide Cheat Sheet: https://peptidecheatsheet.carrd.co/ Download The Bioregulator Cheat Sheet: https://bioregulatorcheatsheet.carrd.co/ 1 On 1 Coaching Application: https://hunterwilliamscoaching.carrd.co/ Book A Call With Me: https://hunterwilliamscall.carrd.co/ Supplement Sources: https://hunterwilliamssupplements.carrd.co/ Amazon Storefront: https://www.amazon.com/shop/hunterwilliams/list/WE16G2223BXA?ref_=cm_sw_r_cp_ud_aipsflist_R7QWQC0P1RACB2ETY3DY Socials: Instagram: https://www.instagram.com/hunterwilliamscoaching/Podcast: https://hunterwilliamspodcast.buzzsprout.com/ Video Topic Request: https://hunterwilliamsvideotopic.carrd.co/ In this video, I break down ATX-304 (also known as OS-01 or OS-03) — a powerful small molecule AMPK activator being studied for fat loss, metabolic health, and longevity. If you’ve heard ATX-304 described as “exercise in a capsule,” you’ll see why after going through the research, mechanisms, human trials, and potential applications. I also share how ATX-304 works differently than GLP-1s, why it preserves muscle while supporting fat loss, and what the future may hold for this compound in anti-aging medicine. 👉 Don’t forget to download the Peptide Cheat Sheet linked below and join my email list for updates on cutting-edge research compounds. ⏱️ Timestamps 0:00 – Intro & what ATX-304 is 0:27 – Why it’s also called OS-01/OS-03 1:06 – Clearing up confusion with skincare OS-01 1:21 – Background & how I discovered ATX-304 2:15 – Why early adoption is expensive & my mission to lower costs 3:00 – What makes ATX-304 different from other mitochondrial supplements 3:14 – Mechanisms, animal trials, human data & dosage overview 4:13 – Discovery & development background (Sweden to Cambrian Biotech) 5:07 – Phase 2 trials in type 2 diabetes (glucose & vascular effects) 6:00 – AMPK explained in simple terms 7:11 – Mechanism of action: preventing dephosphorylation 8:34 – ATX-304 as a dual AMPK + mitochondrial activator 9:34 – Effects on glucose metabolism & insulin sensitivity 10:24 – Why fasting insulin improvements matter 10:42 – Lipid metabolism, fatty liver benefits & cholesterol reduction 12:15 – Fat mass reduction with muscle preservation 13:00 – Why this matters for body composition vs. GLP-1s 14:04 – Cellular stress response & autophagy benefits 15:00 – Vascular and cardiac improvements 16:16 – Diabetes studies: preventing disease progression 17:18 – Anti-aging effects in mice (exercise capacity & insulin sensitivity) 18:02 – Liver protection benefits 18:25 – Kidney protection against toxic injury 19:12 – Vascular disease, aneurysm & neurodegeneration studies 20:06 – Preclinical evidence across multiple organ systems 20:10 – Human trial: 28-day study results 21:04 – Safety profile & side effect comparison to GLP-1s 22:00 – Clinical development & obesity trials 22:18 – Potential in combination with semaglutide 23:00 – Dosage ranges (100–1000mg) & cost considerations 24:14 – Why it reduces insulin burden & cardiovascular risk factors 25:00 – Sustainable fat loss & improved exercise capacity 26:44 – Vascular protection & fatty liver disease applications 27:25 – Neurodegeneration & concussion recovery potential 27:58 – Healthy aging & safety considerations 28:38 – Summary: exercise in a bottle & proven benefits 29:23 – Closing thoughts, gratitude & community message
0:00 / 0:00